TY - JOUR
T1 - Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men
T2 - The VA normative aging study
AU - Jain, Nitin B.
AU - Potula, Vijayalakshmi
AU - Schwartz, Joel
AU - Vokonas, Pantel S.
AU - Sparrow, David
AU - Wright, Robert O.
AU - Nie, Huiling
AU - Hu, Howard
PY - 2007/6
Y1 - 2007/6
N2 - Background: Lead exposure has been associated with higher blood pressure, hypertension, electrocardiogram abnormalities, and increased mortality from circulatory cause. Objective: We assessed the association between bone lead - a more accurate biomarker of chronic lead exposure than blood lead - and risk for future ischemic heart disease (IHD). Methods: In a prospective cohort study (VA Normative Aging Study), 837 men who underwent blood or bone lead measurements at baseline were followed-up for an ischemic heart disease event between 1 September 1991 and 31 December 2001. IHD was defined as either a diagnosis of myocardial infarction or angina pectoris that was confirmed by a cardiologist. Events of fatal myocardial infarction were assessed from death certificates. Results: An IHD event occurred in 98 cases (70 nonfatal and 13 fatal). The mean blood, tibia, and patella lead levels were higher in IHD cases than in noncases. In multivariate Cox-proportional hazards models, one standard deviation increase in blood lead level was associated with a 1.27 (95% confidence interval, 1.01-1.59) fold greater risk for ischemic heart disease. Similarly, a one standard deviation increase in patella and tibia lead levels was associated with greater risk for IHD (hazard ratio for Patella lead = 1.29; 95% confidence interval, 1.02-1.62). Conclusions: Men with increased blood and bone lead levels were at increased risk for future IHD. Although the pathogenesis of IHD is multifactorial, lead exposure may be one of the risk factors.
AB - Background: Lead exposure has been associated with higher blood pressure, hypertension, electrocardiogram abnormalities, and increased mortality from circulatory cause. Objective: We assessed the association between bone lead - a more accurate biomarker of chronic lead exposure than blood lead - and risk for future ischemic heart disease (IHD). Methods: In a prospective cohort study (VA Normative Aging Study), 837 men who underwent blood or bone lead measurements at baseline were followed-up for an ischemic heart disease event between 1 September 1991 and 31 December 2001. IHD was defined as either a diagnosis of myocardial infarction or angina pectoris that was confirmed by a cardiologist. Events of fatal myocardial infarction were assessed from death certificates. Results: An IHD event occurred in 98 cases (70 nonfatal and 13 fatal). The mean blood, tibia, and patella lead levels were higher in IHD cases than in noncases. In multivariate Cox-proportional hazards models, one standard deviation increase in blood lead level was associated with a 1.27 (95% confidence interval, 1.01-1.59) fold greater risk for ischemic heart disease. Similarly, a one standard deviation increase in patella and tibia lead levels was associated with greater risk for IHD (hazard ratio for Patella lead = 1.29; 95% confidence interval, 1.02-1.62). Conclusions: Men with increased blood and bone lead levels were at increased risk for future IHD. Although the pathogenesis of IHD is multifactorial, lead exposure may be one of the risk factors.
KW - Angina
KW - Epidemiology
KW - Myocardial infarction
UR - http://www.scopus.com/inward/record.url?scp=34250161637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250161637&partnerID=8YFLogxK
U2 - 10.1289/ehp.9629
DO - 10.1289/ehp.9629
M3 - Article
C2 - 17589593
AN - SCOPUS:34250161637
SN - 0091-6765
VL - 115
SP - 871
EP - 875
JO - Environmental health perspectives
JF - Environmental health perspectives
IS - 6
ER -